Stock PAIN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Pain Therapeutics, Inc. Nasdaq

Equities

US69562K5065

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
JonesTrading Downgrades Cassava Sciences to Hold From Buy
MT
Cassava Sciences forms internal panel after US probe into two employees
RE
Cassava Sciences forms internal committee after probes by U.S. regulators into two employees
RE
Top Premarket Gainers
MT
HC Wainwright Downgrades Cassava Sciences to Neutral From Buy
MT
Health Care Stocks Slip -- Health Care Roundup
DJ
Cassava Sciences' Shares Down 46% After Adviser Is Indicted
DJ
Cassava Sciences Issues Statement on Former Science Advisor
GL
US professor charged with manipulating data for Alzheimer's drug trial
RE
HC Wainwright Adjusts Price Target on Cassava Sciences to $131 From $124, Maintains Buy Rating
MT
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
AQ
Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
GL
Cassava Sciences Raises More Than $125 Million From Warrant Distribution
MT
Cassava Sciences Announces Over $125 Million Raised from Warrant Distribution
GL
North American Morning Briefing : Stock Futures -2-
DJ
Cassava Sciences : Warrants – Notice of Guaranteed Delivery
PU
Tomorrow is Last Day to Trade SAVAW Warrants on NASDAQ
GL
North American Morning Briefing : Investors Brace -2-
DJ
Cassava Sciences : Corporate Presentation – Second Quarter 2024
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SAVA Stock
  4. Stock
  5. News Pain Therapeutics, Inc.